Advisor Resource Council’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,202
Closed -$995K 339
2025
Q1
$995K Buy
+9,202
New +$950K 0.08% 251
2024
Q4
Sell
-4,441
Closed -$372K 144
2024
Q3
$372K Buy
+4,441
New +$339K 0.17% 151
2024
Q1
Sell
-3,207
Closed -$260K 344
2023
Q4
$260K Buy
+3,207
New +$250K 0.03% 377
2023
Q2
Sell
-2,943
Closed -$243K 205
2023
Q1
$243K Buy
+2,943
New +$244K 0.06% 213
2022
Q3
Sell
-5,990
Closed -$371K 282
2022
Q2
$371K Sell
5,990
-8,644
-59% -$535K 0.03% 341
2022
Q1
$870K Sell
14,634
-4,364
-23% -$279K 0.26% 106
2021
Q4
$1.38M Buy
18,998
+3,698
+24% +$255K 0.11% 191
2021
Q3
$1.07M Sell
15,300
-5,252
-26% -$369K 0.32% 87
2021
Q2
$1.42M Buy
+20,552
New +$1.37M 0.15% 154

Other funds holding GILD

Advisor Resource Council's GILD Position: Q2 2025 in Review

Advisor Resource Council sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 9,202 shares — an estimated $995K sold.

Advisor Resource Council first reported a position in GILD in Q2 2021 and held it in 9 quarters. The position peaked at $1.42M in Q2 2021. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Advisor Resource Council reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Advisor Resource Council sold 9,202 Gilead Sciences shares in Q2 2025, an estimated $995K.
  • Advisor Resource Council first reported a position in Gilead Sciences in Q2 2021 and held it in 9 quarters.
  • Advisor Resource Council's Gilead Sciences position peaked at $1.42M in Q2 2021.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Advisor Resource Council's 13F filing for Q2 2025, filed 11 Aug 2025.